Morgan Stanley Hookipa Pharma Inc. Call Options Transaction History
Morgan Stanley
- $1.27 Trillion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding HOOK
# of Institutions
25Shares Held
13.5MCall Options Held
98.5KPut Options Held
46.6K-
Eco R1 Capital, LLC San Francisco, CA5.72MShares$19.2 Million0.12% of portfolio
-
Knoll Capital Management, LLC Miami, FL5.52MShares$18.5 Million2.2% of portfolio
-
Redmile Group, LLC San Francisco, CA1.06MShares$3.56 Million0.04% of portfolio
-
Royal Bank Of Canada Toronto, A6215KShares$721,7070.0% of portfolio
-
Black Rock Inc. New York, NY125KShares$417,6510.0% of portfolio
About HOOKIPA Pharma Inc.
- Ticker HOOK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 51,654,500
- Market Cap $173M
- Description
- HOOKIPA Pharma Inc., a clinical stage biopharmaceutical company, develops immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform. The company's lead infectious disease product candidate is HB-101, which is in a randomized double-blinded Phase II clinical trial in patients awaiting kidney transpl...